Michael D. Tarantino

Author

Bleeding & Clotting Disorders Institute ORCID

Also Known As

M D Tarantino, M TARANTINO, M Tarantino, M. D. TARANTINO, M. D. Tarantino, M. TARANTINO, M. Tarantino, M.D Tarantino, M.D. TARANTINO, M.D. Tarantino

202

Publications

Citations

H-Index

Concepts

All Affiliations

Bleeding & Clotting Disorders Institute Illinois College Amgen (United States)Indiana Hemophilia and Thrombosis Center Cornell University

About

Michael D. Tarantino is an author at Bleeding & Clotting Disorders Institute specializing in medicine, hematology, and thrombosis.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	24	1.9K
2	Health Sciences	6	6	201
3	Public Health	1	1	69
4	Allergy	1	1	14
5	Anatomy	1	1	44

Michael D. Tarantino

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
Efficacy of romiplostim in patients with chronic immune thrombocytopenic purpura: a double-blind randomised controlled trial David J. Kuter, James B. Bussel, Roger M. Lyons, The Lancet ThrombopoiesisThrombosisAutoimmune DiseaseBlood PlateletImmunology	2008	851
Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination Eun‐Ju Lee, Douglas B. Cines, Terry Gernsheimer, American Journal of Hematology	2021	383
Romiplostim in children with immune thrombocytopenia: a phase 3, randomised, double-blind, placebo-controlled study Michael D. Tarantino, James B. Bussel, Victor S. Blanchette, The Lancet ThrombopoiesisThrombosisBone Marrow FailureAutoimmune DiseaseBlood Platelet	2016	147
The use of recombinant activated factor VII to reverse warfarin-induced anticoagulation in patients with hemorrhages in the central nervous system: preliminary findings Julian Lin, William C. Hanigan, Michael D. Tarantino, Journal of neurosurgery	2003	141
Clinical evaluation of an advanced category antihaemophilic factor prepared using a plasma/albumin‐free method: pharmacokinetics, efficacy, and safety in previously treated patients with haemophilia A<sup>1</sup> Michael D. Tarantino, Peter W. Collins, C. R. M. Hay, Haemophilia	2004	138
Single dose of anti-D immune globulin at 75μg/kg is as effective as intravenous immune globulin at rapidly raising the platelet count in newly diagnosed immune thrombocytopenic purpura in children Michael D. Tarantino, Guy Young, Salvatore Bertolone, The Journal of Pediatrics ThrombopoiesisThrombosisBlood PlateletPediatric HematologyAnti-d Immune Globulin	2006	112
Value of Isolated IgA Anti–β<sub>2</sub>‐Glycoprotein I Positivity in the Diagnosis of the Antiphospholipid Syndrome Vijaya Murthy, Rohan Willis, Zurina Romay‐Penabad, Arthritis & Rheumatism	2013	106
Selective validation of the WHO Bleeding Scale in patients with chronic immune thrombocytopenia Patrick Fogarty, Michael D. Tarantino, Andrés Brainsky, Current Medical Research and Opinion	2011	102
Evaluation of bleeding and thrombotic events during long‐term use of romiplostim in patients with chronic immune thrombocytopenia (ITP) Terry Gernsheimer, James N. George, Louis M. Aledort, Journal of Thrombosis and Haemostasis InflammationThrombosisBlood PlateletChronic Immune ThrombocytopeniaImmunodeficiencies	2010	100
An Outbreak of Synthetic Cannabinoid–Associated Coagulopathy in Illinois Amar H. Kelkar, Nichole A. Smith, Annia Martial, New England Journal of Medicine	2018	85

Page 1